IMAP technology
Until now, assays of kinase activity have been performed using radioactive isotopes or highly specific antibodies. To address this, Molecular Devices introduced its proprietary IMAP® Technology, providing a non-radioactive, homogeneous assay applicable to a wide variety of kinases without regard for the substrate peptide sequences. The assay is a simple “mix-and-read” procedure that allows accurate determination of enzyme activity